GEODE CAPITAL MANAGEMENT, LLC
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in SUPN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$73,024,792
-$10,894,645 QoQ
Shares Held
1,570,088
-3.3% QoQ
Ownership
2.70%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 335 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $4,788,152,578 across 66 Drug Manufacturers - Specialty & Generic names. SUPN ranks #14 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
13,289,622 | $954,992,236 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
996,598 | $539,986,694 | |
| 3 | VTRS |
Viatris Inc
|
32,807,906 | $520,989,547 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,607,196 | $393,251,799 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,138,777 | $360,469,474 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
11,302,057 | $278,143,622 | |
| 7 | ALKS |
Alkermes plc.
|
4,477,876 | $234,640,702 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,841,367 | $204,281,254 |
All Filings in SUPN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,024,792 | 1,570,088 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $83,919,437 | 1,623,514 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $73,203,080 | 1,472,899 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $67,385,046 | 1,410,024 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $44,115,706 | 1,399,610 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $43,446,772 | 1,326,619 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $54,622,138 | 1,510,568 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $46,210,350 | 1,482,051 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $37,653,647 | 1,407,613 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $44,580,064 | 1,306,950 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $36,034,756 | 1,245,154 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $30,136,684 | 1,093,097 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $31,687,628 | 1,054,146 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $37,588,371 | 1,037,493 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $35,903,531 | 1,006,547 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $32,120,603 | 948,910 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $27,159,957 | 939,141 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $30,057,826 | 930,007 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $28,043,405 | 961,708 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $25,310,176 | 949,013 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $27,886,225 | 905,691 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $22,766,756 | 869,624 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $20,013,043 | 795,431 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $15,902,128 | 763,058 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $18,356,541 | 772,907 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $13,642,590 | 758,343 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||